KROS
Keros Therapeutics Inc.
Company Overview
| Mkt Cap | $631.98M | Price | $15.22 |
| Volume | 666.20K | Change | +1.26% |
| P/E Ratio | -3.4 | Open | $15.05 |
| Revenue | $3.5M | Prev Close | $15.03 |
| Net Income | $-187.4M | 52W Range | $9.12 - $72.37 |
| Div Yield | N/A | Target | $23.00 |
| Overall | 50 | Value | 55 |
| Quality | 42 | Technical | 54 |
No chart data available
Stock Overview
Updated DailyKeros Therapeutics Inc. (KROS) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $15.22 with a market capitalization of $631.98 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows KROS with a volume of 666K shares. The stock opened up 0.13% from yesterday's close of $15.03. Current analyst estimates project earnings of $0.33 per share for this year, with next year targeting $-4.78.
KROS demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for KROS include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 51.1%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 08:14 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $15.22 | +1.3% | 666.20K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |